CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism
26 Agosto 2024 - 7:00AM
Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands
will exhibit at the 46th ESPEN Congress on Clinical Nutrition &
Metabolism in Milan, Italy on September 7-10, 2024. ESPEN 2024
offers a unique platform for companies to present and educate on
innovative science in clinical nutrition and metabolism, fostering
collaboration with physicians, dietitians, pharmacists,
nutritionists, scientists, and nurses.
The NAI and CarnoSyn® Brands team will be
available at stand #16 to discuss the latest clinical evidence of
TriBsyn™, a patent-pending formula that utilizes proprietary
technology to increase beta-alanine bioavailability and absorption,
while effectively eliminating the common paresthesia sensation
associated with efficacious dosages of beta-alanine. TriBsyn™
provides new opportunity to reach untapped consumers from older
adults to vegans and anyone focused on wellness. Congress attendees
are invited to visit the stand to learn more about this new product
innovation.
Aaron Starr, Vice President, CarnoSyn® Brands
stated, “We are excited to exhibit TriBsyn™ at this year’s ESPEN
Congress on Clinical Nutrition and Metabolism and to share details
behind the clinically proven formula. There is an evolving need and
growing demand for healthy aging and wellness solutions, and this
proprietary carnosine booster is a game changer for dietary
supplement categories, as well as for fortified and medical foods,
seeking benefit focus on muscle vitality, cognitive performance,
and anti-aging support.”
Following ESPEN, the team will attend the 20th
European Geriatric Medicine Society (EuGMS) Congress in Valencia,
Spain on September 18-20.
Find out more about TriBsyn™ by visiting ESPEN
stand #16 or www.tribsyn.com.
About CarnoSyn® Brands:
CarnoSyn® Brands feature three clinically studied, patented
ingredients available exclusively from Natural Alternatives
International, Inc.: CarnoSyn® instant release beta-alanine
powder, SR CarnoSyn® sustained release beta-alanine tablets,
and TriBsyn™ powder. In 2019, CarnoSyn® beta-alanine successfully
obtained NDI status from the FDA and received Self-Affirmed GRAS
(Generally Recognized as Safe) status. SR CarnoSyn®, an advanced
delivery form of CarnoSyn®, received GRAS affirmation in 2017. The
new “paresthesia-free” TriBsyn™ powder allows NAI to broaden their
product offerings within the dietary supplement category, including
medical and other fortified food products. To learn more about SR
CarnoSyn® in active nutrition and wellness, visit
www.srcarnosyn.com. For more information about the latest
innovation, TriBsyn™, visit www.tribsyn.com.
About NAI:NAI, headquartered in
Carlsbad, California, is a leading formulator, manufacturer and
marketer of nutritional supplements and provides strategic
partnering services to its customers. NAI’s comprehensive
partnership approach offers a wide range of innovative nutritional
products and services to clients including scientific research,
proprietary ingredients, customer-specific nutritional product
formulation, product testing and evaluation, marketing management
and support, packaging and delivery system design, regulatory
review, and international product registration assistance. For more
information about NAI, please visit www.nai-online.com.
Contact:Renee
MichaelsonDirector of Global Marketing
NAI/CarnoSyn® Brands(760) 736-7700info@nai-online.com
Natural Alternatives (NASDAQ:NAII)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Natural Alternatives (NASDAQ:NAII)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024